Neogen Corporation ( NEOG ) NASDAQ Global Select

Cena: 4.79 ( -1.64% )

Aktualizacja 06-26 22:00
NASDAQ Global Select
Branża: Medical - Diagnostics & Research
Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna

Notowania:

Informacje o spółce:
Sektor: Zdrowie
Branża: Medical - Diagnostics & Research
Zatrudnienie: 2 917
Giełda: NASDAQ Global Select
Ilość akcji w obrocie: 100%
Ilość akcji: 216 520 000
Debiut giełdowy: 1989-08-23
WWW: https://www.neogen.com
CEO: Mr. John Edward Adent
Adres: 620 Lesher Place
Siedziba: 48912 Lansing
ISIN: US6404911066
Opis firmy:

Neogen Corporation, wraz z spółkami zależnymi, rozwija, produkuje i sprzedaje różne produkty dla bezpieczeństwa żywności i zwierząt na całym świecie. Działa przez dwa segmenty, bezpieczeństwo żywności i bezpieczeństwo zwierząt. Segment bezpieczeństwa żywności oferuje zestawy do testów diagnostycznych i powiązane produkty w celu wykrywania niebezpiecznych i niezamierzonych substancji w żywności i karmienia dla zwierząt, w tym patogeny przenoszone przez żywność, organizmy psucia, naturalne toksyny, alergeny żywnościowe, modyfikacje genetyczne, produkty uzupełniające przeżuwacze, speakowanie mięsa, pozostałości narkotykowe, pozostałości pestycydów i ogólnych problemach sanitarnych; oraz Accupoint zaawansował test szybkiego sanitaru w celu wykrycia obecności trifosforanu adenozyny, chemikalia występującego w żywych komórkach. Ten segment oferuje swoje produkty przede wszystkim producentom i procesorom żywności i pasz; producenci i procesory zboża; Producenci ciastek, krakersów, cukierków, lodów i innych przetworzonej żywności; procesory mięsa i drobiu, procesory owoców morza, producenci owoców i warzyw oraz mleczarnie; laboratoria; oraz producenci farmaceutyków, kosmetyków i szczepionek weterynaryjnych. Segment bezpieczeństwa zwierząt zapewnia instrumenty weterynaryjne, farmaceutyki, szczepionki, miejscowe, pasożytniki, produkty diagnostyczne, rodentycydy, środki czyszczące, środki dezynfekujące, środki owadobójcze i genomowe na rynku bezpieczeństwa zwierząt. Ten segment oferuje różne produkty dla naukowców do wykrywania substancji aktywnych biologicznie. Zestawy testowe testowania testów wykrywania leków są stosowane do wykrywania wykorzystywanych i terapeutycznych leków u zwierząt rolniczych i wyścigowych; Wykrywanie pozostałości leków w mięsie i produktach mięsnych; oraz zastosowania leków leków kryminalistycznych na ludziach. Ponadto produkty tego segmentu są wykorzystywane do utrzymania warunków sanitarnych i ograniczenia potencjalnych zagrożeń związanych z bakteriami, grzybami i wirusami. Neogen Corporation został zarejestrowany w 1981 roku i ma siedzibę w Lansing w stanie Michigan.

Wskaźniki finansowe
Kapitalizacja (USD) 1 039 612 020
Aktywa: 4 503 173 000
Cena: 4.79
Wskaźnik Altman Z-Score: 1.7
Słaby (wysokie ryzyko bankructwa)
Dywidenda: 0
P/E: -2.1
Ilość akcji w obrocie: 100%
Średni wolumen: 6 874 462
Ilość akcji 217 038 000
Wskaźniki finansowe
Przychody TTM 912 199 000
Zobowiązania: 1 367 981 000
Przedział 52 tyg.: 3.87 - 18.58
Piotroski F-Score: 2
Słaby (niska jakość finansowa)
EPS: -2.2
P/E branży: 30.3
Beta: 1.223
Raport okresowy: 2025-07-28
WWW: https://www.neogen.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Douglas E. Jones Chief Operating Officer & Vice President 692 156 1970
Mr. John Edward Adent President, Chief Executive Officer & Director 1 389 880 1968
Mr. John Moylan Vice President, Corporate Controller & Chief Accounting Officer 0 0
Ms. Amy M. Rocklin Ph.D. Chief Legal & Compliance Officer and Corporate Secretary 0 1973
Mr. Bill Waelke Head of Investor Relations 0 0
Dr. Robert S. Donofrio Ph.D. Vice President & Chief Scientific Officer 0 1975
Ms. Julie A. Mann Vice President & Chief Human Resources Officer 0 1965
Sarah Demey Administrative Manager 0 0
Mr. David H. Naemura Chief Financial Officer 0 1970
Wiadomości dla Neogen Corporation
Tytuł Treść Źródło Aktualizacja Link
Neogen Announces Board Transition with Appointment of Andrea Wainer and Retirement of James P. Tobin LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that James P. Tobin has chosen to retire from the Company's Board of Directors, effective May 31, 2025. Mr. Tobin has served on Neogen's Board since 2016 and currently chairs the Governance and Sustainability Committee and serves on the Audit Committee. James C. Borel, Chair of the Neogen Board of Directors, will serve as the interim Chair of the Governance and Sus. businesswire.com 2025-05-13 20:05:00 Czytaj oryginał (ang.)
Why Is Neogen (NEOG) Up 6.4% Since Last Earnings Report? Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? zacks.com 2025-05-09 16:30:46 Czytaj oryginał (ang.)
Neogen: A Fair Divestment (Rating Upgrade) Neogen's merger with 3M Food Safety led to significant debt and operational struggles, causing shares to plummet and the CEO to be ousted. Following disappointing sales and earnings, the company is exploring asset sales and restructuring, offering potential upside if stabilization occurs. Neogen's current valuation appears modest relative to sales, presenting a speculative opportunity for investors willing to take on risk. seekingalpha.com 2025-04-23 07:13:53 Czytaj oryginał (ang.)
Neogen Announces Sale of Cleaners & Disinfectants Business LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today it has entered into a definitive agreement to sell its global cleaners and disinfectants business to Kersia Group (“Kersia”), a global leader in biosecurity, disinfection and hygiene solutions, for $130 million in cash at closing plus contingent consideration tied to the future performance of the business. The transaction is expected to be accretive to margins and c. businesswire.com 2025-04-21 13:00:00 Czytaj oryginał (ang.)
Neogen Stock Tumbles on Q3 Earnings & Sales Miss, Margins Contract NEOG posts lower-than-expected earnings and revenues for the third quarter of fiscal 2025. zacks.com 2025-04-10 12:30:39 Czytaj oryginał (ang.)
Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Neogen (NEOG) give a sense of how the business performed in the quarter ended February 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2025-04-09 23:00:39 Czytaj oryginał (ang.)
Crude Oil Down 4%; Neogen Shares Plunge After Q3 Results U.S. stocks traded mixed midway through trading, with the Dow Jones index falling more than 100 points on Wednesday. benzinga.com 2025-04-09 16:06:32 Czytaj oryginał (ang.)
Neogen Corporation (NEOG) Q3 2025 Earnings Call Transcript Neogen Corporation (NASDAQ:NEOG ) Q3 2025 Earnings Conference Call April 9, 2025 8:00 AM ET Company Participants Bill Waelke - VP, IR John Adent - CEO and President David Naemura - CFO Conference Call Participants Brandon Vazquez - William Blair Subbu Nambi - Guggenheim Thomas DeBourcy - Nephron Research David Westenberg - Piper Sandler Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation Third Quarter Fiscal Year 2025 Earnings Conference Call. [Operator Instructions] This call is being recorded on Wednesday, April 9, 2025. seekingalpha.com 2025-04-09 15:43:41 Czytaj oryginał (ang.)
Neogen (NEOG) Lags Q3 Earnings and Revenue Estimates Neogen (NEOG) came out with quarterly earnings of $0.10 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.12 per share a year ago. zacks.com 2025-04-09 13:10:42 Czytaj oryginał (ang.)
Neogen Q3 Earnings Fall Short On Expectations, Cuts Guidance Amid Macro Headwinds And Tariff Concerns Neogen Corp. NEOG reported third-quarter 2025 adjusted EPS of 10 cents on Wednesday, down from 12 cents a year ago, missing the consensus of 11 cents. benzinga.com 2025-04-09 12:47:59 Czytaj oryginał (ang.)
Neogen® Announces CEO Transition LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, today announced that John Adent, the Company's CEO and President, will be stepping down after an eight-year career at the Company. Mr. Adent will continue to serve in his existing roles until his successor has been appointed. Neogen's Board of Directors has formed a special committee, comprising Board Chair Jim Borel, Thierry Bernard and Jeff Capello, to direct the search for the. businesswire.com 2025-04-09 11:01:00 Czytaj oryginał (ang.)
Neogen Announces Third-Quarter 2025 Results LANSING, Mich.--(BUSINESS WIRE)--Neogen Corporation (NASDAQ: NEOG) announced today the results of the third quarter ended February 28, 2025. "During the third quarter, we continued to make good progress on the integration and saw a solid underlying performance in our Food Safety segment,” said John Adent, Neogen's President and Chief Executive Officer. “The quarter was impacted by lower sample collection revenue, but we made significant improvements in our sample collection production and reach. businesswire.com 2025-04-09 11:00:00 Czytaj oryginał (ang.)
Neogen® Announces Refinancing of Term Loan and Revolving Credit Facility LANSING, Mich.--(BUSINESS WIRE)--Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today the successful refinancing of the remaining $550 million principal of its original $650 million term loan, as well as its revolving credit facility, due in August 2027. The new $450 million term loan and $250 million revolving credit facility mature in April 2030, extending the previous maturity by over two and a half years. With an upsizing of the Company's revolv. businesswire.com 2025-04-07 13:00:00 Czytaj oryginał (ang.)
Seeking Clues to Neogen (NEOG) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics Evaluate the expected performance of Neogen (NEOG) for the quarter ended February 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. zacks.com 2025-04-04 14:15:26 Czytaj oryginał (ang.)
Neogen Announces Third-Quarter Earnings Release Date LANSING, Mich. , March 20, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) will issue its third-quarter earnings release before the opening of the market on Wednesday, April 9, 2025. prnewswire.com 2025-03-20 18:15:00 Czytaj oryginał (ang.)
NLRB Withdraws Unfair Labor Practices Claim Against Neogen® LANSING, Mich. , Feb. 18, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today the National Labor Relations Board (NLRB) has withdrawn its unfair labor practices claim against the Company. prnewswire.com 2025-02-18 18:33:00 Czytaj oryginał (ang.)
Baron Small Cap Fund: Q4 2024 Top Contributors And Detractors Vertiv Holdings Co. excels with strong AI-related data center demand, projecting 16%-18% organic revenue growth for 2025, and increased profit margins. Chart Industries, Inc. shows robust fundamentals with record revenue and margins, expecting 12% revenue and 18% EBITDA growth in 2025. Intapp, Inc. benefits from strong quarterly results, 17% revenue growth, and a record pipeline, driven by AI product demand and favorable M&A activity. seekingalpha.com 2025-01-31 00:10:00 Czytaj oryginał (ang.)
Neogen® Introduces Igenity® BCHF to Help Industry Mitigate Bovine Congestive Heart Failure Risk LINCOLN, Neb. , Jan. 21, 2025 /PRNewswire/ --  Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food security solutions, announced today the launch of Igenity® BCHF to improve overall bovine heart health standards. prnewswire.com 2025-01-21 10:45:00 Czytaj oryginał (ang.)
NEOG Stock Gains Following the Launch of Its New MDA2QSAL96 Kit Neogen launches the new Molecular Detection Assay 2 - Quantitative Salmonella (MDA2QSAL96) to deliver consistency and sensitivity with an easy-to-use workflow that saves time and resources. zacks.com 2025-01-17 11:11:14 Czytaj oryginał (ang.)
Neogen® Launches New MDA2 Quantitative Salmonella Molecular Detection Assay LANSING, Mich. , Jan. 16, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today the launch of the new Neogen Molecular Detection Assay 2 – Quantitative Salmonella (MDA2QSAL96). prnewswire.com 2025-01-16 10:45:00 Czytaj oryginał (ang.)
NEOG Prelim Q2 Earnings Meet, '25 Sales View Down, Stock Falls NEOG's Food Safety business witnesses a slight year-over-year decrease in revenues for the second quarter of fiscal 2025. zacks.com 2025-01-15 11:01:19 Czytaj oryginał (ang.)
Neogen Corporation (NEOG) Q2 2025 Earnings Call Transcript Neogen Corporation (NASDAQ:NEOG) Q2 2025 Earnings Conference Call January 10, 2024 8:00 AM ET. seekingalpha.com 2025-01-10 12:50:22 Czytaj oryginał (ang.)
Neogen (NEOG) Q2 Earnings Match Estimates Neogen (NEOG) came out with quarterly earnings of $0.11 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.11 per share a year ago. zacks.com 2025-01-10 11:25:37 Czytaj oryginał (ang.)
Neogen Announces Preliminary¹ Second-Quarter 2025 Results Revenue of $231.3 million. Net loss of $456.3 million due to non-cash goodwill impairment; $(2.10) per diluted share. prnewswire.com 2025-01-10 09:00:00 Czytaj oryginał (ang.)
Neogen® To Participate in Upcoming Investor Conferences LANSING, Mich. , Jan. 7, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in two upcoming investor conferences. prnewswire.com 2025-01-07 10:45:00 Czytaj oryginał (ang.)
Exploring Analyst Estimates for Neogen (NEOG) Q2 Earnings, Beyond Revenue and EPS Besides Wall Street's top -and-bottom-line estimates for Neogen (NEOG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended November 2024. zacks.com 2025-01-06 12:21:17 Czytaj oryginał (ang.)
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down NEOG faces intense competition due to the development of new technologies by competitors, which could affect the marketability and profitability of its products. zacks.com 2025-01-03 12:46:16 Czytaj oryginał (ang.)
Neogen® Announces Change to Second-Quarter Earnings Release Date LANSING, Mich. , Jan. 2, 2025 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that, due to U.S. equity markets being closed in observance of the National Day of Mourning for former U.S. President Jimmy Carter, it will now issue its second-quarter earnings release before the opening of the market on Friday, January 10, 2025. prnewswire.com 2025-01-02 18:15:00 Czytaj oryginał (ang.)
Neogen® Announces Second-Quarter Earnings Release Date LANSING, Mich. , Dec. 19, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) will issue its second-quarter earnings release before the opening of the market on Thursday, January 9, 2025. prnewswire.com 2024-12-19 10:45:00 Czytaj oryginał (ang.)
NEOG Stock Gains From New Addition to the Petrifilm Product Line Neogen expands the Petrifilm product line with the introduction of Petrifilm Bacillus cereus Count Plate. zacks.com 2024-12-18 10:41:09 Czytaj oryginał (ang.)
Neogen® Launches Petrifilm® Bacillus cereus Count Plate to Enhance Food Safety Testing Efficiency LANSING, Mich. , Dec. 17, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, has introduced a new addition to its Petrifilm® product line, the Neogen Petrifilm Bacillus cereus Count Plate. prnewswire.com 2024-12-17 10:45:00 Czytaj oryginał (ang.)
Neogen® to Participate in the 36th Annual Piper Sandler Healthcare Conference LANSING, Mich. , Nov. 27, 2024 /PRNewswire/ -- Neogen Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 36th Annual Piper Sandler Healthcare Conference in New York City on Wednesday, December 4, 2024. prnewswire.com 2024-11-27 10:45:00 Czytaj oryginał (ang.)
Competitive Pressure, Macroeconomic Woes Weigh on NEOG Stock NEOG faces intense competition resulting from competitors' development of new technologies, which could affect the marketability and profitability of its products. zacks.com 2024-11-14 12:40:16 Czytaj oryginał (ang.)
Neogen® To Participate in 2024 UBS Global Healthcare Conference LANSING, Mich. , Nov. 5, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 UBS Global Healthcare Conference in Rancho Palos Verdes, California, on Tuesday, November 12. prnewswire.com 2024-11-05 10:45:00 Czytaj oryginał (ang.)
Neogen Q1 Earnings Miss Estimates, Margins Crash NEOG's Food Safety and Animal Safety businesses witness a year-over-year decrease in revenues in the first quarter of fiscal 2025. zacks.com 2024-10-15 13:56:10 Czytaj oryginał (ang.)
Neogen Stock: Expect Volatility To Continue Amid Weak Growth Neogen reported its Q1 earnings, which missed expectations. Weak demand trends across food and animal safety end markets have pressured the sales outlook. We expect shares to remain volatile until there is evidence of a growth rebound. seekingalpha.com 2024-10-11 21:31:59 Czytaj oryginał (ang.)
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2024-10-10 21:00:15 Czytaj oryginał (ang.)
Neogen Corporation (NEOG) Q1 2025 Earnings Call Transcript Neogen Corporation (NASDAQ:NEOG ) Q1 2025 Earnings Conference Call October 10, 2024 8:00 AM ET Company Participants Bill Waelke - Vice President, Investor Relations & Treasury John Adent - Chief Executive Officer Dave Naemura - Chief Financial Officer Conference Call Participants David Westenberg - Piper Sandler Brandon Vazquez - William Blair Thomas DeBourcy - Nephron Research Operator Good morning, ladies and gentlemen, and welcome to the Neogen Corporation First Quarter 2025 Earnings Call. At this time, all lines are in listen-only mode. seekingalpha.com 2024-10-10 17:42:08 Czytaj oryginał (ang.)
Neogen (NEOG) Misses Q1 Earnings Estimates Neogen (NEOG) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to earnings of $0.11 per share a year ago. zacks.com 2024-10-10 13:05:27 Czytaj oryginał (ang.)
Neogen Announces First-Quarter 2025 Results Revenue of $217.0 million. Net loss of $12.6 million; $(0.06) per diluted share. prnewswire.com 2024-10-10 11:00:00 Czytaj oryginał (ang.)
Insights Into Neogen (NEOG) Q1: Wall Street Projections for Key Metrics Evaluate the expected performance of Neogen (NEOG) for the quarter ended August 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight. zacks.com 2024-10-07 14:16:19 Czytaj oryginał (ang.)
Neogen Announces the Appointment of New Board Member LANSING, Mich. , Oct. 1, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that it has appointed Thierry Bernard as a director to its Board, effective November 1, 2024. prnewswire.com 2024-10-01 12:45:00 Czytaj oryginał (ang.)
Neogen® Announces First-Quarter Earnings Release Date LANSING, Mich. , Sept. 19, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) will issue its first-quarter earnings release before the opening of the market on Thursday, October 10, 2024. prnewswire.com 2024-09-19 12:45:00 Czytaj oryginał (ang.)
Is the Options Market Predicting a Spike in Neogen (NEOG) Stock? Investors need to pay close attention to Neogen (NEOG) stock based on the movements in the options market lately. zacks.com 2024-09-13 13:41:13 Czytaj oryginał (ang.)
Neogen® To Participate in 2024 Wells Fargo Healthcare Conference LANSING, Mich. , Aug. 29, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG) announced today that the Company will participate in the 2024 Wells Fargo Healthcare Conference in Boston, Massachusetts, on Thursday, September 5. prnewswire.com 2024-08-29 12:45:00 Czytaj oryginał (ang.)
Neogen Suffers From Competitive Pressure, Macroeconomic Woes NEOG faces intense competition, which could affect the marketability and profitability of its products. zacks.com 2024-08-28 17:56:04 Czytaj oryginał (ang.)